Cargando…
Targeted Drug Delivery to Hepatic Stellate Cells for the Treatment of Liver Fibrosis
Liver fibrosis is caused by excessive accumulation of extracellular matrix during chronic liver injuries. Although clinical evidence suggests that liver fibrosis can be reversed, there is no standard therapy for liver fibrosis. Moreover, there is a lack of diagnostic tools to detect early-stage live...
Autores principales: | Chen, Zhijin, Jain, Akshay, Liu, Hao, Zhao, Zhen, Cheng, Kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Pharmacology and Experimental Therapeutics
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6806344/ https://www.ncbi.nlm.nih.gov/pubmed/30886124 http://dx.doi.org/10.1124/jpet.118.256156 |
Ejemplares similares
-
Targeted Drug Delivery for Chronic Nonmalignant Pain: Longitudinal Data From the Product Surveillance Registry
por: Schultz, David M., et al.
Publicado: (2021) -
DDEL-15. NANOTHERAPEUTIC TARGETING OF TUMOR ENDOTHELIUM FOR ENHANCING DRUG DELIVERY PAST THE BLOOD-BRAIN BARRIER
por: Kiguchi, Hiro, et al.
Publicado: (2020) -
Optimizing and Evaluating the Transdermal Permeation of Hydrocortisone Transfersomes Formulation Based on Digital Analysis of the In Vitro Drug Release and Ex Vivo Studies
por: Abdelwahd, Asmae, et al.
Publicado: (2022) -
The Application of Failure Modes and Effects Analysis Methodology to Intrathecal Drug Delivery for Pain Management
por: Saulino, Michael F., et al.
Publicado: (2016) -
DDEL-04. ENGINEERED NANOCARRIERS TO ENHANCE DRUG DELIVERY ACROSS THE BLOOD-BRAIN BARRIER
por: Straehla, Joelle P, et al.
Publicado: (2020)